Sitemap

The Fresenius group
Group key figures
To our shareholders
Summary of the fiscal year
Fresenius shares
Stock changes
Capital structure
Dividend
Shareholder structure
Earnings per share
Analysts recommendations
Investor relations
Business segments
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Fresenius worldwide
Transparency & Governance
Report of the Supervisory Board
Corporate governance declaration
Declaration of Conformity
Relevant disclosures on corporate governance practices
Management Board and Supervisory Board procedures
Management Board procedures
Supervisory Board procedures
Cooperation between the Management and Supervisory Boards
Supervisory Board efficiency evaluation
Composition and procedures of the Supervisory Board committees
Audit Committee
Personnel Committee
Nomination Committee
Mediation Committee
“Transaction Financing APP Pharmaceuticals, Inc.” Committee
Compensation Report
Compensation of the Management Board
Commitments to members of the Management Board for the event of the termination of their appointment
Miscellaneous
Adjustments to to system of compensation of the Management Board
Information on the supervisory board
Corporate governance
Shareholders
Annual General Meeting
Avoidance of conflicts of interest
Directors’ dealings
Transparency and communication
Risk management and control system
Financial accounting and reporting
Directors & Officers Insurance
Compliance
Management Board & Supervisory Board
Management Board
Supervisory Board
Management report
Operations and business environment
Group structure and business
Management and control
Key products, services, and business processes
Important markets and competitive position
Legal and economic factors
Capital, shareholders, statutes
Corporate performance criteria, goals, and strategy
Strategy and goals
Overall business development
Economic environment
Health care industry
The Management Board ’s assessment of the general economic developments
Significant factors affecting operating performance
The Management Board ’s assessment of business results
Comparison of the actual business results with the forecasts
Results of operations, financial position, assets and liabilities
Results of operations
Sales
Earnings structure
Reconciliation to adjusted earnings
Development of other major items in the statement of income
Value added
Financial position
Financial management policies and goals
Financing
Effect of off-balance-sheet financing instruments
Liquidity analysis
Dividend
Cash flow analysis
Investments and acquisitions
Assets and liabilities
Asset and liability structure
Currency and interest risk management
Non-financial performance indicators and other success factors
Employees
Human resources management
Talent management
Job application management
Idea management
Vocational training management
Profit-sharing scheme and stock option plan
Research and development
Fresenius Medical Care
Fresenius Kabi
Fresenius Biotech
Procurement
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Quality management
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Responsibility, environmental management, sustainability
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Sales, marketing, and logistics
Overall assessment of the business situation
Opportunities and risk report
Opportunities management
Risk management
Risk areas
General economic risks
Risks in the general operating framework
Risks in the health care sector
Operating risks
Assessment of overall risk
Corporate rating
Subsequent events
Outlook
General and mid-term outlook
Future markets
Economic outlook
Health care sector and markets
Group sales and earnings
Sales and earnings by business segment
Financing
Investments
Procurement
Research and development
Corporate structure and organization
Planned changes in human resources and the social area
Dividend
Financial statements
Consolidated statement of income
Consolidated statement of comprehensive income
Consolidated statement of financial position
Consolidated statement of cash flows
Statement of changes in equity
Segment reporting
Notes
General notes
1. Principles
2. Acquisitions and divestitures
Notes on the consolidated statement of income
3. Special items
4. Sales
5. Cost of sales
6. Cost of materials
7. Personnel expenses
8. Selling, general and administrative expenses
9. Net interest
10. Other financial result
11. Taxes
12. Earnings per share
Notes on the consolidated statement of financial position
13. Cash and cash equivalents
14. Trade accounts receivable
15. Inventories
16. Other current and non-current assets
17. Property, plant and equipment
18. Goodwill and other intangible assets
19. Other accrued expenses
20. Other liabilities
21. Debt and capital lease obligations
22. Senior Notes
23. Mandatory Exchangeable Bonds
24. Trust preferred securities
25. Pensions and similar obligations
26. Noncontrolling interest
27. Fresenius SE shareholders’ equity
28. Other comprehensive income (loss)
Other notes
29. Commitments and contingent liabilities
30. Financial instruments
31. Supplementary information on capital management
32. Supplementary information on the consolidated statement of cash flows
33. Notes on segment reporting
34. Stock options
35. Related party transactions
36. Subsequent events
Notes in accordance with the German Commercial Code (HGB)
37. Compensation of the Management Board and the Supervisory Board
38. Auditor’s fees
39. Corporate Governance
40. Proposal for the distribution of earnings
41. Responsibility statement
Auditor`s report

QUICKFINDER

History

My Annual report

Tools

IR-Services